Square Pharmaceuticals Ltd. reported earnings results for the first quarter ended September 30, 2022. For the first quarter, the company reported sales was BDT 18,813.28 million compared to BDT 17,417.54 million a year ago. Revenue was BDT 16,069.63 million compared to BDT 14,876.86 million a year ago.

Net income was BDT 5,500.32 million compared to BDT 4,996.67 million a year ago. Basic earnings per share from continuing operations was BDT 6.2 compared to BDT 5.64 a year ago.